ESR1 and neuroendocrine carcinoma: Ultrasound guided core needle biopsy revealed poorly differentiated neuroendocrine carcinoma/small cell carcinoma (Figures 2A,B), estrogen receptor (ER) negative, progesterone receptor (PR) positive (10% weak intensity), and human epidermal growth receptor 2 (HER2) negative.